Treace Medical Concepts, Inc.

TMCI

US89455T1097

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq Other stock markets 04:00:00 2024-06-27 pm EDT			5-day change	1st Jan Change
6.64 ^USD	+5.56%		+13.31%	-47.92%

Jun. 24	Treace Medical Concepts, Inc.(NasdaqGS:TMCI) dropped from S&P Healthcare Equipment Select Industry Index	CI
May. 29	Treace Medical Concepts Insider Bought Shares Worth $253,475, According to a Recent SEC Filing	MT

Treace Medical Concepts, Inc.(NasdaqGS:TMCI) dropped from S&P Healthcare Equipment Select Industry Index

June 23, 2024

Latest news about Treace Medical Concepts, Inc.

Treace Medical Concepts, Inc.(NasdaqGS:TMCI) dropped from S&P Healthcare Equipment Select Industry Index	Jun. 23	CI
Treace Medical Concepts Insider Bought Shares Worth $253,475, According to a Recent SEC Filing	May. 29	MT
North American Morning Briefing : The "Everything -2-	May. 17	DJ
UBS Downgrades Treace Medical Concepts to Neutral From Buy, Cuts Price Target to $6.50 From $16	May. 16	MT
Transcript : Treace Medical Concepts, Inc. Presents at Bank of America Health Care Conference 2024, May-15-2024 02:20 PM	May. 15
Top Midday Decliners	May. 08	MT
UBS Adjusts Price Target on Treace Medical Concepts to $16 From $17, Maintains Buy Rating	May. 08	MT
Truist Downgrades Treace Medical Concepts to Hold From Buy, Cuts PT to $7 From $17; Notes Slowing Growth Outlook Amid Rising Competitive Pressures	May. 08	MT
Top Premarket Decliners	May. 08	MT
Truist Securities Downgrades Treace Medical Concepts to Hold From Buy, Lowers Price Target to $7 From $17	May. 08	MT
BTIG Downgrades Treace Medical Concepts to Neutral From Buy	May. 08	MT
JPMorgan Downgrades Treace Medical Concepts to Neutral From Overweight, Cuts Price Target to $8 From $15	May. 08	MT
Stifel Downgrades Treace Medical Concepts to Hold From Buy, Cuts Price Target to $6 From $15	May. 08	MT
Treace Medical Concepts Falls 57% Premarket After Revising 2024 Sales Outlook to $201-$211 Million From $220-$225 Million	May. 08	MT
Earnings Flash (TMCI) TREACE MEDICAL CONCEPTS Reports Q1 Revenue $51.1M, vs. Street Est of $49.1M	May. 07	MT
Transcript : Treace Medical Concepts, Inc., Q1 2024 Earnings Call, May 07, 2024	May. 07
Treace Medical Concepts, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 07	CI
Treace Medical Concepts, Inc. Revises Earnings Guidance for the Full-Year 2024	May. 07	CI
Treace Medical Concepts Treats 100,000 Patients With Lapiplasty Bunion Correction	Mar. 25	MT
Transcript : Treace Medical Concepts, Inc., Q4 2023 Earnings Call, Feb 27, 2024	Feb. 27
Treace Medical Concepts, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 27	CI
Earnings Flash (TMCI) TREACE MEDICAL CONCEPTS Reports Q4 Revenue $62.2M, vs. Street Est of $60.2M	Feb. 27	MT
Treace Medical Concepts, Inc. Provides Revenue Guidance for the Year 2024	Feb. 27	CI
Treace Medical Concepts, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Feb. 27	CI
Treace Medical Concepts Says Post-Market Study of Lapiplasty Shows Patients Report 'Positive' Outcomes	Feb. 02	MT

Chart Treace Medical Concepts, Inc.

Duration

Period

More charts

Treace Medical Concepts, Inc. is a medical technology company. The Company is focused on advancing the standard of care for the surgical management of bunion and related midfoot deformities. It has patented the Lapiplasty 3D Bunion Correction System a combination of instruments, implants, and surgical methods designed to surgically correct all three planes of the bunion deformity and secure the unstable joint, addressing the root cause of the bunion and helping patients get back to their active lifestyles. It also has Adductoplasty Midfoot Correction System, designed for reproducible surgical correction of the midfoot as well as its Hammertoe PEEK Fixation System designed to address hammertoe, claw toe and mallet toe deformities. The Lapiplasty, Adductoplasty and Hammertoe PEEK Fixation Systems are comprised of single-use implant kits and reusable instrument trays. The Company sells these products to physicians, surgeons, hospitals and ambulatory surgery centers in the United States.

Sector

Medical Equipment, Supplies & Distribution

Calendar

2024-08-05 - Q2 2024 Earnings Release (Projected)

Related indices

Russell 2000

More about the company

Income Statement Evolution

More financial data

Ratings for Treace Medical Concepts, Inc.

Trading Rating

Investor Rating

ESG Refinitiv

C-

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

6.64 USD

Average target price

6.833 USD

Spread / Average Target

+2.91%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Medical Equipment

	1st Jan change	Capi.
TREACE MEDICAL CONCEPTS, INC.	-47.92%	412M
SHOCKWAVE MEDICAL	+75.69%	12.57B
MASIMO CORPORATION	+12.19%	6.98B
PENUMBRA, INC.	-30.47%	6.78B
JIANGSU YUYUE MEDICAL EQUIPMENT & SUPPLY CO., LTD.	+9.17%	5.2B
GETINGE AB	-19.91%	4.59B
APT MEDICAL INC.	+16.71%	4.15B
ASAHI INTECC CO., LTD.	-21.37%	3.83B
INARI MEDICAL, INC.	-27.62%	2.73B
SKAN GROUP AG	-0.99%	2B

Medical Equipment